Today, product design process is facing a market globalisation led by distributed teams. The international market context, in which industrial companies evolve, leads design teams to work in a large multidisciplinary collaborative context using collaborative practices. In this context, product design process is driven by the integration and optimisation of stakeholders’ collaboration. Thus, to facilitate collaborative steps, new management strategies are defined and new information systems can be used. To this end, we have focused our article on the topic of collaborative product design project management. We have underlined the necessity to use quantitative and non-intrusive indicators during the management of collaborative design phases besides subjective evaluations. Tracking these indicators is performed in parallel to the existing approaches in order to evaluate the performance of collaborative design project. Moreover, these indicators can show the impact of the collaboration steps on the design project evolution. The computation of proposed indicators is based on precise metrics which details the completeness of the computer-aided design model and its evolution depending on the used collaborative tools and the project milestones. This computation uses the importance of each computer-aided design model part and the transformation rate of each part of the computer-aided design model.
Background: Accurate evaluation of the Near Point of Convergence (NPC) is essential for diagnosing and managing convergence insufficiency (CI). Conventional assessment relies on the patient’s verbal feedback and the examiner’s visual observation, making it subjective and examiner-dependent. The AI-based MobileS platform, previously validated for both diagnosis and home-based therapy of CI, enables smartphone-based measurement and visualisation of NPC through eye tracking, without the need for verbal responses or additional equipment. This study, the third stage of our research programme, examined how ophthalmologists interpret NPC data when presented as videos versus AI-derived graphs. Methods: Twenty-two ophthalmologists completed an online questionnaire with 20 NPC test cases from the validated MobileS database, presented as both silent videos and AI-derived graphs. Accuracy was analysed using mixed-effects logistic regression, and continuous error was assessed using clustered bootstrap. Results: Graph-based interpretation showed higher odds of accurate NPC identification than video-based interpretation at the primary ±5 mm threshold (OR = 19.7, 95% CI: 13.50–28.74; p < 0.0001). Absolute error was lower for graphs than videos (Graphs − Videos: −22.73 mm; 95% CI: −26.88 to −18.59; p < 0.0001). “Uncertain” responses occurred in 28.2% of video-based assessments and 0% of graph-based assessments. Off-target errors decreased from 50.2% (videos) to 3.6% (graphs). Conclusions: AI-derived graphs of eye-movement data were associated with improved NPC estimation, suggesting a potential role in supporting clinical and tele-ophthalmology workflows.
Background: This study innovatively combines Artificial Intelligence (AI) algorithms with smartphone technology, automatically detecting the Near Point of Convergence (NPC) and diagnosing Convergence Insufficiency (CI) without the need for extra diagnostic tools and, notably, without having to rely on the subject’s vocal response, marking an unprecedented approach in the field to the best of our knowledge. Methods: This was a prospective study that enrolled 86 participants. The real-time tracking of eye structures and movements was conducted using AI technologies integrated with a mobile application (MobileS). Participants brought the smartphone closer, focusing on a target displayed on the screen. The system calculated pupillary distance (PD) and phone-to-face distance, incorporating a unique feature called the exodeviation episode’s counter (ExoCounter) to determine the NPC. Additionally, participants underwent testing using the RAF Ruler test (RulerT), considering the ground truth. Results: MobileS demonstrated significant correlation with the RulerT, as evidenced by a Pearson correlation coefficient of 0.74 (p < 0.001) and an Intraclass Correlation Coefficient (ICC) of 0.73 (p < 0.001), highlighting its reliability and consistency with conventional ophthalmic testing. Additionally, the system exhibited notable sensitivity and specificity in diagnosing CI. Notably, user feedback indicated a preference for the MobileS, with 71% of participants favouring it for its ease of use and comfort. Conclusions: MobileS is a precise, user-friendly tool for independent NPC measurement, applicable in tele-ophthalmology and home-based care. Its versatility extends beyond CI diagnosis, marking a significant advancement in ophthalmic diagnostics for accessible and efficient eye care.
Background: Convergence insufficiency (CI) is a common binocular vision disorder that causes eye strain, headaches, and blurriness. Although pencil push-ups (PPU) are widely used to treat CI, their real-world effectiveness may be limited by inconsistent performance and poor adherence. MobileS (the App) is an AI-based smartphone application that tracks eye movements through the front camera, enabling guided “digital push-ups” with instant visual feedback and automatic performance monitoring. This follow-up study evaluated the feasibility, recorded adherence, and preliminary clinical signals of MobileS as a home-based therapy for CI compared with conventional PPU. Methods: Twenty-five participants with CI were randomly assigned to either the App group (n = 12) or the PPU group (n = 13) for 8 weeks of home-based training. Both groups performed convergence push-ups—using the app or a pencil. NPC was measured using a RAF ruler at baseline, mid-point, and endpoint. Symptom severity was assessed using the Convergence Insufficiency Symptom Survey (CISS), and adherence was recorded automatically by the app or manually by participants. Results: All 25 randomized participants completed all three NPC assessment points. The App group showed a statistically significant improvement in NPC from baseline to study completion (mean improvement = 2.81 cm, p = 0.007), whereas the PPU group showed no significant change. Recorded adherence was higher in the App group compared with the PPU group (90.1% vs. 75.4%, p = 0.0069). The App group showed a significant reduction in symptom severity (p = 0.049). Between-group differences in symptom change were not statistically significant. Conclusions: MobileS appears feasible as a home-based CI management tool, and was associated with higher recorded adherence and preliminary NPC improvement signals. Larger, adequately powered studies are needed to confirm efficacy, particularly for symptoms, and guide teleophthalmology implementation.